Methecillin Resistant Staphylococcal aureus (MRSA) isolates from a hepatology intensive care unit in Egypt: A silent killer

Experimental and Clinical Hepatology

Volumn 8, Issue 1-2, 2012, Pages 35-44

  Gad, Yahia Z ^a   Talaat, Nahla A ^b  

^a MANSOURA UNIVERSITY   (Egypt)

^b MANSOURA UNIVERSITY   (Egypt)

Author keywords

Methicillin; Prevalence; Resistance; Staphylococcus aureus

Indexed keywords

ADULT; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL GENE; BACTERIUM COLONY; BACTERIUM ISOLATE; CHRONIC ACTIVE HEPATITIS; DIARRHEA; FEMALE; HEPATIC ENCEPHALOPATHY; HOSPITALIZATION; HUMAN; INTENSIVE CARE; MAJOR CLINICAL STUDY; MALE; MEDICAL HISTORY; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS INFECTION; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; SEPTICEMIA; SOCIAL STATUS;

EID: 84873119404     PISSN: 17343038     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Chaix C, Durand-Zaleski I, Alberti C, Brun-Buisson C: Control of methicillin-resistant Staphylococcus aureus; a cost-benefit analysis in an intensive care unit. JAMA, 1999; 282: 1745-51
2. Holmes A, Ganner M, McGuane S et al: Staphylococcus aureus isolates carrying Pantom-Valentine leucocidin genes in England and Wales: Frequency, characterization and association with clinical disease. J Clin Microbiol, 2005; 43: 2384-90
3. Marinez JL, Baquero F: Mutation frequencies and antibiotic resistance. Antimicrob. Agents Chemother, 2000; 44: 1771-77
4. Ayliffe GA: The progressive intercontinental spread of Methicillinresistant Staphylococcus aureus. Clin Infect Dis, 1997; 24: S74-79
5. Henderson DK: Managing methicillin-resistant staphylococci: A paradigm for preventing nosocomial transmission of resistant organisms. Am J Infect Control, 2006; 34: S46-54
6. Blair JE, Lennette EH, Truant JP: Manual of clinical microbiology. American society for Microbiology, Bethesda, M.D. 1970; 303
7. Harbarth S: Control of endemic methicillin-resistant Staphylococcus aureus-recent advances and future challenges. Clin Microbiol Infect, 2006; 12: 1154-62
8. th edn. Churchill Livingstone, New York. Ch, 1996; 11: 245-61 44
9. rd edn. London and New York, 2000; 43: 483-622
10. Cheesbrough M: In: District Laboratory Practice in Tropical Countries. Part 2. Cambridge University Press. Cambridge, UK, 2000; 11: 1978-97
11. Brown DF, Edwards DI, Hawkey PM et al: Guidelines for the laboratory diagnosis and susceptibility testing of methicillin-resistant Staphyloccocus aureus (MRSA). J Antimicrob Chemother, 2005; 56: 1000-18
12. Clinical and Laboratory Standard Institute (CLSI) Performance standards for antimicrobial susceptibility testing, CLSI, approved standards M100-S15., Wayne, PA. 2008
13. th ed., Vol. I, Churchill Livingstone, New York, 1996; 131-44
14. Bauer A, Kirby W, Sherris W, Turck M: Antibiotic susceptibility testing by a standardized single disc method. Am J Clin Pathol, 1966; 45: 493-96
15. National Committee for Clinical Laboratory Standards. Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria that Grow Aerobically: Approved Standards M7-A6 and M100-S13. NCCLS, Wayne, PA, USA, 2003
16. Clark RB, Sanders CC, Pakiz CB, Hostetter MK: Aminoglycoside resistance among Pseudomonas aeruginosa isolates with an unusual disk diffusion antibiogram. Antimicrob. Agents Chemother, 1988; 32(5): 689-92
17. Gallagar SR: Electrophoretic separation of proteins. In: Ausubel FM, Brent R, Kingston RE et al (eds.). Current protocols in Molecular Biology. Green Publishing Associates and Wiley Intersience, NY, USA, 1987; 2: 10-21
18. Sanger F, Nicklen S, Coulson AR: DNA sequencing with chain-terminating inhibitors. Proc. Natl Acad Sci, 1977; 74: 5463-67
19. th informational supplement, 1999: 18(1)
20. Diekema DJ, Boots-Miller BJ, Vaughn TE et al: Antimicrobial resistance trends and outbreaks in United States hospitals. Clin Infect, 2004; 38: 78-85
21. Engemann JJ, Carmeli Y, Cosgrove SE et al: Adverseclinical and economic outcomes attributable to methicillin resistance among patients with Staphylococcus aureus surgical site infection. Clin Infect Dis, 2003; 36: 592-98
22. Borzio M, Salerno F, Piantoni L: Bacterial infection in patients with advanced cirrhosis: a multicenter prospective study. Dig Liver Dis, 2001; 33: 41-48
23. CDC: Four pediatric deaths from community-acquired methicillin resistant Staphylococcus aureus Minnesota and North Dakota, 1997-1999. MMWR Morb Mortal Wkly Rep, 1999; 48: 707-10
24. th General Meeting of the American Society for Microbiology, BD Diagnostics. Sparks, MD 2004; 21152, USA
25. Gales AC, Jones RN, Turnidge J et al: Characterization of Pseudomonas aeruginosa isolates: occurrence rates, antimicrobial susceptibility patterns and molecular typing in the global SENTRY antimicrobial surveillance program 1997-1999. Clin Infect Dis, 2001; 32: 46-55
26. Chambers HF, Xiang Q, Liu L et al: Efficacy of levofloxacin for experimental aortic-valve endocarditis in rabbits infected with viridans group streptococcus or Staphylococcus aureus. Antimicrob. Agents Chemother, 1999; 43: 2742-46
27. Bisognano C, Vaudaux P, Rohner P et al: Induction of fibronectin-binding proteins and increased adhesion of quinolone-resistant Staphylococcus aureus by subinhibitory levels of ciprofloxacin. Antimicrob. Agents Chemother, 2000; 44: 1428-37
28. th edition ed. Washington, D.C: ASM Press, 2003
29. Ito T, Okuma K, Ma XX et al: Insights on antibiotic resistance of Staphylococcus aureus from its whole genome: genomic island SCC. Drug Resist Update, 2003; 6: 41-52
30. Skov R, Smyth R, Larsen AR et al: Phenotypic detection of methicillin resistance Staphylococcus aureus by disk diffusion testing and E test on Mueller-Hinton agar. J Clin Microbiol, 2006; 44: 4395-99
31. Rajan L, Smyth E, Humphreys H: Screening for MRSA in ICU patients. How does PCR compare with culture J Infection, 2007; 55: 353-57